These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9378450)

  • 1. [Therapy of Parkinson disease. 2: New therapy concepts for treating motor symptoms].
    Kuhn W; Müller T
    Fortschr Neurol Psychiatr; 1997 Aug; 65(8):375-85. PubMed ID: 9378450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current therapy of idiopathic Parkinson disease. 2: Recent and alternative therapies].
    Müller T; Kuhn W; Przuntek H
    Fortschr Med; 1997 May; 115(13):37-41. PubMed ID: 9324476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of Parkinson disease. 1: Standard therapy of motor and non-motor symptoms].
    Kuhn W; Müller T
    Fortschr Neurol Psychiatr; 1997 Aug; 65(8):361-74. PubMed ID: 9378449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Future aspects of modern Parkinson therapy].
    Ransmayr G; Jeschow M
    Wien Med Wochenschr; 1995; 145(13):299-301. PubMed ID: 7571655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical aspects and conservative therapy of Parkinson disease].
    Dengler R
    Zentralbl Neurochir; 1995; 56(4):148-52. PubMed ID: 8571692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical development of gene therapy for Parkinson's disease.
    Porras G; Bezard E
    Exp Neurol; 2008 Jan; 209(1):72-81. PubMed ID: 17904121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can we achieve neuroprotection with currently available anti-parkinsonian interventions?
    Olanow CW
    Neurology; 2009 Feb; 72(7 Suppl):S59-64. PubMed ID: 19221316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future therapies for Parkinson's disease.
    Hauser RA; Lyons KE
    Neurol Clin; 2004 Oct; 22(3 Suppl):S149-66. PubMed ID: 15501363
    [No Abstract]   [Full Text] [Related]  

  • 10. Ten-Hertz stimulation of subthalamic nucleus deteriorates motor symptoms in Parkinson's disease.
    Timmermann L; Wojtecki L; Gross J; Lehrke R; Voges J; Maarouf M; Treuer H; Sturm V; Schnitzler A
    Mov Disord; 2004 Nov; 19(11):1328-33. PubMed ID: 15389990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current preclinical findings on substances against Parkinson's disease].
    Gerlach M; Riederer P
    Nervenarzt; 2003 Mar; 74 Suppl 1():S2-6. PubMed ID: 12624677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Idiopathic Parkinson syndrome--current therapy].
    Ludin HP
    Ther Umsch; 1993 Nov; 50(11):771-4. PubMed ID: 8191382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment challenges in early stage Parkinson's disease.
    Tetrud J
    Neurol Clin; 2004 Oct; 22(3 Suppl):S19-33. PubMed ID: 15501364
    [No Abstract]   [Full Text] [Related]  

  • 14. [Parkinson disease. Directed use of modern therapy].
    Möller JC; Wächter T; Oertel WH
    MMW Fortschr Med; 2001 May; 143 Suppl 2():45-50. PubMed ID: 11434257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parkinson therapy 2001, especially apomorphine in idiopathic Parkinson syndrome].
    Gutknecht C
    Praxis (Bern 1994); 2001 Jun; 90(23):1024-34. PubMed ID: 11447722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New medical and surgical treatments for Parkinson's disease.
    Klockgether T; Löschmann PA; Wüllner U
    Curr Opin Neurol; 1994 Aug; 7(4):346-52. PubMed ID: 7952244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient].
    Ceballos-Baumann AO
    MMW Fortschr Med; 2002 May; Suppl 2():37-43. PubMed ID: 12070848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Insight: new drugs in development for Parkinson's disease.
    Colosimo C; Fabbrini G; Berardelli A
    Nat Clin Pract Neurol; 2006 Nov; 2(11):600-10. PubMed ID: 17057747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective agents in Parkinson's disease: clinical evidence and caveats.
    Hälbig TD; Tse W; Olanow CW
    Neurol Clin; 2004 Oct; 22(3 Suppl):S1-S17. PubMed ID: 15501359
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnosis and therapy of Parkinson's disease].
    Wittstock M; Benecke R
    MMW Fortschr Med; 2005 May; 147 Spec No 2():28-31. PubMed ID: 15968869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.